Literature DB >> 20602561

Cardiac amyloidosis: an approach to diagnosis and management.

Omaira Halwani1, Diego H Delgado.   

Abstract

Cardiac amyloidosis is a myocardial disease characterized by extracellular amyloid infiltration throughout the heart. Cardiac amyloidosis has a wide spectrum of clinical manifestations but the most frequent presentation is heart failure. Differential diagnoses from other restrictive cardiomyopathies is important. A combination of clinical, electrocardiographic and imaging methods is commonly used to diagnose this disease. Definite diagnosis is based on endomyocardial biopsy and treatment of cardiac amyloidosis is a challenge. Heart transplantation, although controversial, has demonstrated survival benefit.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20602561     DOI: 10.1586/erc.10.41

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  6 in total

Review 1.  Pathophysiology and treatment of cardiac amyloidosis.

Authors:  Morie A Gertz; Angela Dispenzieri; Taimur Sher
Journal:  Nat Rev Cardiol       Date:  2014-10-14       Impact factor: 32.419

2.  Cardioverter-defibrillator implantation in myeloma-associated cardiac amyloidosis.

Authors:  Alfonso Campanile; Fabiola B Sozzi; Ciro Canetta; Gian Battista Danzi
Journal:  Exp Clin Cardiol       Date:  2013

3.  An unexpected mortality following cardiac surgery: a post-mortem diagnosis of cardiac amyloidosis.

Authors:  Gerard J Fitzmaurice; Victoria Wishart; Alastair N J Graham
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-10-21

4.  Cerebral embolism secondary to cardiac amyloidosis: A case report and literature review.

Authors:  Xu-Dong Zhang; Ying-Xian Liu; Xiao-Wei Yan; Li-Gang Fang; Quan Fang; Da-Chun Zhao; Yi-Ning Wang
Journal:  Exp Ther Med       Date:  2017-10-13       Impact factor: 2.447

5.  Right Ventricle Outflow Obstruction in Biventricular Hypertrophic Cardiomyopathy in Amyloidosis.

Authors:  Hamza Sanoussi; Najla Kourireche; Latifa Oukerraj; Mohammed Cherti
Journal:  Eur J Case Rep Intern Med       Date:  2017-10-02

6.  Crystal structure of 6aJL2-R24G light chain variable domain: Does crystal packing explain amyloid fibril formation?

Authors:  Enrique Rudiño-Piñera; Ángel E Peláez-Aguilar; Carlos Amero; Adelaida Díaz-Vilchis
Journal:  Biochem Biophys Rep       Date:  2019-08-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.